▶ Domestic bio venture company UNDBIO announced on the 8th that it has succeeded in manufacturing a prototype of insulin, a diabetes treatment.
▶ After manufacturing and clinical trials of clinical prototypes this year, the company aims to produce insulin in Korea by 2025.
▶ Plan to enter global markets such as the United States and Europe in 2027.
▶ Increased convenience to inject only once a week, and the advantage of minimizing inflammation in the injection site.
▶ The goal is to gain a differentiated competitive edge in the global insulin market, focusing on insulin injection manufacturing technology once a week.